| Identification | Back Directory | [Name]
Creatine riboside | [CAS]
1616693-92-5 | [Synonyms]
Creatine riboside
2-{2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-
oxolan-2-yl]-1-methylcarbamimidamido}acetic acid | [Molecular Formula]
C9H17N3O6 | [MDL Number]
MFCD31618423 | [MOL File]
1616693-92-5.mol | [Molecular Weight]
263.248 |
| Chemical Properties | Back Directory | [Boiling point ]
525.2±60.0 °C(Predicted) | [density ]
1.71±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
3.40±0.10(Predicted) | [color ]
Light brown to brown |
| Hazard Information | Back Directory | [Description]
Creatine riboside (CR) is a novel metabolite of cancer metabolism. It is a urinary diagnostic biomarker of lung and liver cancer risk and prognosis. The level of CR is highly positive correlated in tumor and urine indicating that it is derived from human lung and liver cancers. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
|